21st.BIO
PrivateLast Round
VC Round
Dec 21, 2021
Momentum
Top 10%
of companies Caplight tracks
Company Overview
21st.BIO operates in Healthcare & Life Sciences and is based in Denmark. Its latest recorded funding round was a VC Round in December 2021.
21st.BIO is a bioindustrial company that provides a precision fermentation technology platform to help companies scale up from laboratory-level molecule innovation to cost-effective, large-scale production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
21st.BIO Comparables
Compare 21st.BIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cauldron | 82% | |
| Perfect Day | 78% | |
| The Protein Express | 77% |
For institutional investors. Book with your work email.
21st.BIO Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
21st.BIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Holdings | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 17, representing 26% of headcount.
- Jul 20, 2026
Open roles increased to 17, 26% of headcount.
For institutional investors. Book with your work email.
21st.BIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 21st.BIO's valuation, stock price, and market status.
Is 21st.BIO a public or private company?
21st.BIO is a private company.
What is the current stock price of 21st.BIO?
21st.BIO is a private company, so its shares have no public market price. Caplight tracks 21st.BIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 21st.BIO worth (valuation)?
Valuation information for 21st.BIO is not publicly available.
Can I buy 21st.BIO stock?
21st.BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 21st.BIO's last funding round?
21st.BIO's most recent funding round was VC Round on December 21, 2021.
Who are the main investors in 21st.BIO?
Key investors in 21st.BIO include Novo Holdings.
Will 21st.BIO IPO soon?
No public IPO plans have been announced for 21st.BIO.
How can I track 21st.BIO secondary market activity?
Caplight tracks bids, offers, and trades in 21st.BIO's shares on secondary markets.